A. A. , A. Mc, and R. P. , Organization of central nervous system dopaminergic pathways, J Neural Transm, vol.22, pp.3-17, 1986.

A. X. , M. J. , C. J. , C. J. , L. M. et al., Anatomy of the temporomandibular joint, Semin Ultrasound CT MRI, issue.3, pp.28-170, 2007.

A. Academy and O. Periodontology, Treatment of plaqueinduced gingivitis, chronic periodontitis, and other clinical conditions, Am Acad Ped Dent, issue.6, pp.36-360, 2004.

A. Dental, Do you have dry mouth?, J Am Den Assoc, vol.133, p.1455, 2002.

A. Psychiatric, Diagnostic and Statistical Manual of Mental Disorders : text revision. 4e éd. Washington: American psychiatric association, 2000.

A. Sl, Transcriptional control of midbrain dopaminergic neuron development, Development, issue.18, pp.133-3499, 2006.

A. S. , B. A. , B. C. , C. N. , C. C. et al., Dénutrition : une pathologie méconnue en société d'abondance [en ligne] Periodontal therapy and systemic inflammation in type 2 diabetes mellitus: a meta-analysis, PLoS One, vol.10, issue.53, pp.128344-128356, 2008.

B. N. La-dysphagie, B. Hs, D. Sn, and N. Amerongen-av, Le clinicien. [en ligne] Ecstasy (MDMA) and oral health, Br Dent J, vol.1815, issue.2, pp.69-74, 2006.

B. Jh, The pharmacology of Chlorpromazine and Promethazine, Proc R Soc Med, issue.8, pp.47-617, 1954.

C. Rd and C. Wl, Oral colonization by candida albicans, Crit Rev Oral Biol Med, vol.10, issue.3, pp.359-83, 1999.

C. De, The relationship of pharmacology to side effects, J Clin Psychiatry, issue.10, pp.58-55, 1997.

C. , G. M. , M. P. , B. A. Epstein-jb, and . Silverman-s-jr, Attestation de formation aux gestes et soins d'urgence. [en ligne]. [consulté le 25 Assessment of the use of sialogogues in the clinical management of patients with xerostomia, Spec Care Dentist, vol.15, issue.264, pp.164-70, 2006.

C. B. , L. Js, R. O. , and J. M. , Bruxisme du sommeil : aspects findamentaux et cliniques, JPIO, vol.18, pp.277-289, 1999.

C. G. , L. C. , and D. Fiorino, A romantic delusion: de Clerambault's syndrome in dementia, Geriatr Gerontol Int, vol.2012, issue.123, pp.383-390

C. Gt and R. S. , Four oral motor disorders: bruxism, dystonia, dyskinesia and drug-induced dystonic extrapyramidal reactions, Dent Clin North Am, vol.51, issue.1, pp.225-268, 2007.

D. Almeida-pdv, G. Amt, M. Man, A. De-lima-aas, and . Lr, Saliva composition and functions : a comprehensive review, J Contemp Dent Pract, vol.3, issue.9, pp.72-80, 2008.

D. Araujo, A. Do, D. Ma, B. Sena-ep, and . Af, Temporomandibular disorders in patients with schizophrenia using antipsychotic agents: a discussion paper, Drug Healthc Patient Saf, vol.6, pp.21-28, 2014.

D. Gieter, F. S. Deb, A. E. Bk, D. T. , R. M. et al., Les troubles de la deglutition en 10 questions Disponible à partir de : https://www.chu-brugmann.be/fr/edu/dysphagia/brochure.pdf 41 The effectiveness of aripiprazole in the management of problem behavior in people with intellectual disabilities, developmental disabilities and/or autistic spectrum disorder: a systematic review, Res Dev Disabil, vol.15, issue.3, pp.35-711, 2014.

D. Hs, The psychiatric works of Emil Kraepel a many-faceted story of modern medicine, J Hist Neurosci, vol.13, issue.3, pp.248-76, 2004.

D. A. , U. T. , G. E. , and B. Fa, The relationship between bruxism and occlusal factors among seven-to 19-year-old Turkish children

D. C. , W. , and H. Xf, The role of histaminergic H1 and H3 receptors in food intake: a mechanism for atypical antipsychoticinduced weight gain?, Prog Neuropsychopharmacol Biol Psychiatry, vol.34, issue.1, pp.1-4, 2010.

D. J. Ian and S. L. , Exposure to antipsychotics and risk of stroke: self controlled cased series study, British Med J, issue.7670, pp.337-616, 2008.

D. Fj, Saliva and dental caries, Dent Clin North Am, vol.43, issue.4, pp.579-97, 1999.

D. P. Précis, F. Tk, B. A. , F. P. , H. P. et al., Les voies aero-digestives supérieures Caen : Solal Molecular mechanisms of taste recognition: considerations about the role of saliva, Int J Mol Sci, issue.23, pp.16-5945, 2009.

F. G. , R. C. , P. F. , and M. H. Quezada, Psychotropic drugs and bruxism, Expert Opin Drug Saf, vol.2014, issue.10, pp.13-1319

F. Kn, G. X. , V. E. , and R. Z. , Class effect of pharmacotherapy in bipolar disorder: fact or misbelieve, Ann Gen Psychiatry, vol.10, issue.1, p.8, 2011.

F. N. Neuroleptiques, F. , and T. F. , disponible à partir de : http://www.isc.cnrs.fr/jea/Neuroleptiques Pharmacologie et mode d'action des neuroleptiques, EMC Psychiatrie, vol.15, pp.1-12, 2005.

G. Wf, Physiologie médicale. 2 e éd. Buxelles : De Boek, 2005.

H. Pm and W. A. , Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management, Drugs, issue.20, pp.64-2291, 2004.

H. Al and G. , Serotonergic hallucinogens as translation models relevant to schizophrenia, Int J Neuropsychopharmacol, vol.2013, issue.10, pp.16-2165

H. Aw, M. N. , and C. Pg, Effect of clazamine, olanzapine and haloperidol on the microstructure of ingestive behaviour in the rat, Psychopharmacology, vol.167, issue.2, pp.115-137, 2003.

H. , A. Am, D. S. , M. Ss, P. D. et al., Antipsychotics in adults with schizophrenia: comparative effectiveness of first-generation versus second-generation medications: a systematic review and meta-analysis, Ann Intern Med, issue.7, pp.157-498, 2012.

H. K. , C. S. , and S. Ma, Temporomandibular joint pain and dysfunction. Current Pain and Headache Reports, pp.408-414, 2006.

H. Sp and W. Rt, A review of saliva: Normal composition, flow, and function, J Prosth Dent, vol.85, issue.2, pp.162-169, 2001.

I. Mr, W. Se, and S. Pj, Occlusal splints and quality of life ? does patient-provider relationship matter? Oral Health Prev Dent, pp.249-58

J. Bc and G. Gt, The evolution of psychiatric symptoms in Alzheimer disease: a natural history study, J Am Geriat Society, issue.9, pp.44-1078, 1996.

K. Rm, A. Ms, R. P. , L. R. , J. K. et al., Occupancy of striatal and extrastriatal dopamine D2 receptors by clozapine and quetiapine, Neuropsychopharmacol, issue.9, pp.31-1991, 2006.

K. M. Schuld-a, H. H. , D. M. , S. A. , W. Pm et al., Clozapine and olanzapine are associated with food craving and binge eating: results from a randomized double-blind study, J Clin Psychopharmacol, issue.6, pp.27-662, 2007.

L. Bl, C. Ch, C. Ky, T. E. , and C. W. , Antipsychotic exposure and type 2 diabetes among patients with schizophrenia: a matched case-control study of California Medicaid claims, Pharmacoepidemiol Drug Saf, issue.6, pp.14-417, 2005.

L. T. Neuroleptiques, L. Ml, R. Ph, M. C. , G. F. De-grandmont-p et al., Disponible à partir de http://users.skynet.be/bk323595/ES.html 78 Reduction of sleep bruxism using a mandibular advancement device: an experimental controlled study, Int J Prosthodont, vol.15, issue.6, pp.19-549, 2006.

L. He and B. Ta, The history of the psychopharmacology of schizophrenia, Can J Psychiatry, vol.42, issue.2, pp.152-162, 1997.

L. V. , K. A. , and M. C. Kotler-m, Vitamin B6 in treatment of tardive dyskinesia: a preliminary case study, Clin Neuropharmacol, vol.22, issue.4, pp.241-244, 1999.

L. H. , B. T. , P. Mf, and O. Jp, 40 years of neuroleptic drugs, Ann Med Psychol, issue.3, pp.151-271, 1993.

M. Cr, M. Ec, T. Mr, S. Ab, . Prado et al., Pharmacotherapy for sleep bruxism Occlusal splints for treating sleep bruxism (tooth grinding) Cochrane Database Syst Rev La sédation et l'analgésie en réanimation [en ligne] Drug treatment of schizophrenia. Overview of recent research, Cochrane Database Syst Rev Schizophr Res, vol.4, issue.2, pp.81-90, 1991.

M. K. Borosi, F. P. , and M. M. , Evaluation of unstimulated flow rates of whole and palatal saliva in healthy patient wearing complete dentures and in patients with Sjogren's syndrome, J Prosthet Dent, issue.6, pp.91-577, 2004.

M. Bt, . Mauri, P. S. Mc, M. M. , C. A. et al., Physiology of oral cavity, pharynx and upper esophageal sphincter. GI Mobility online DOI:10.1038/gimo2 94 Review article: clinical pharmacology os atypical antipsychotic, an update, EXCLI J, vol.13, pp.1163-1191, 2006.

M. Am, S. S. , H. Od, O. Brien-m, M. R. et al., Effects of long-term prolactin-raising antipsychotic medication on bone mineral density in patients with schizophrenia, Br J Psychiatry, issue.6, pp.184-503, 2004.

M. Hy, L. Z. , K. Y. , and I. J. , Serotonin receptors: their key role in drugs to treat schizophrenia, Prog Neuropsychopharmacol Biol Psychiatry, issue.7, pp.27-1159, 2003.

M. F. Fernandez-pardal-m, G. M. , A. J. , G. R. , and P. Ic, Bruxism secondary to chronic antidopaminergic drug exposure, Clin Neuropharmacol, vol.16, issue.4, pp.315-338, 1993.

9. Mravak-stipetic-m, Xerostomia -diagnosis and treatment, Med Scie, vol.38, pp.69-91, 2012.

M. Mr and C. Cl, Distinguishing akathisia and tardive dyskinesia: a review of the literature, J Clin Psychopharmacol, vol.3, issue.6, pp.343-50, 1983.

M. Rv, R. P. , and M. A. , Bruxism: conceptual discussion and review, J Pharm Bioallied Scie, vol.7, issue.1, pp.265-270, 2015.

N. Institute, . Dental, . Craniofacial, and . Research, Temporomandibular join disorders. [en ligne]. [consulté le 03

N. Pacheco-bv, M. Gonzalez-al, and M. Carrasco-m, Utility of quetiapine in tardive dyskinesia, Actas Esp Psiquiatr, issue.6, pp.31-347, 2003.

N. Fh, Atlas d'anatomie humaine. 4 e éd, 2007.

O. Jp, G. T. , and D. E. , Le livre de l'interne : psychiatrie. 2 e éd

O. Mondiale-de, L. S. Diabète-110, . Organisation, L. De, and . Santé, Disponible à partir de : http://www.who.int/mediacentre International Statistical Classification of Diseases and Related Health Problems 10th Revision, 2010.

O. Wg, H. P. , and J. J. , Tetrabenazine treatment for tardive dyskinesia: assessment by randomized videotape protocol, Am J Psychiatry, issue.8, pp.156-1279, 1999.

R. R. , D. Mg, S. Ak, K. C. , P. S. et al., Evaluation of oral health in type II diabetes mellitus patients, Oral Maxill Pathol J, vol.6, issue.1, pp.525-531, 2015.

R. Dl and G. Cm, Pharmacological treatment of binge eating disorder: update review and synthesis, Expert Opin Pharmacother, issue.10, pp.16-1463, 2015.

R. Jl, K. Hs, and K. Ay, The effect of accute xerostomia on vocal function, Arch Otolaryngol Head Neck Surg, issue.5, pp.132-542, 2006.

S. J. , F. Ma, C. K. , and S. Fg, Salivary hypofunction: an update on aetiology, diagnosis and therapeutics, Arch Oral Biol, vol.60, issue.2, pp.242-55, 2015.

S. Bl, R. Dg, and W. Mg, Recognizing and managing antipsychotic drug treatment side effects in the elderly, J Clin Psychiatry, vol.6, issue.2, pp.14-19, 2004.

S. Ge, B. Jd, and O. S. Pge2, IL-1 beta, TNF-alpha responses in diabetics as modifiers of periodontal disease expression, Ann Periodontol, vol.3, issue.1, pp.40-50, 1998.

S. L. , A. M. , C. P. , G. S. , L. S. et al., Recommandations formalisées d'experts de l'AFPBN : prescription des neuroleptiques et antipsychotiques d'action prolongée, pp.2014-189

S. Ge, S. He, F. Ca, and W. Kf, Type 2 diabetes and oral health: a comparison between diabetic and nondiabetic subjects, Diab Reas Clinic Pract, vol.50, issue.1, pp.27-34, 2000.

S. Fa and S. K. , Oral health disparities in older adults: oral bacteria inflammation, and aspiration pneumonia, Dent Clin North Am, vol.2014, issue.584, pp.771-82

S. Jr and C. Da, Newer oral atypical antipsychotic agents: a review, pp.36-832, 2011.

S. Jr, Cigarette smoking and clinically significant drug interactions, Ann Pharmacother, issue.11, pp.29-1139, 1995.

S. Sh, N. Sw, and S. Cg, Schizophrenia: a review, Am Fam Physician, issue.12, pp.75-1821, 2007.

S. Ta and M. Dj, Antipsychotic induced weight gain: genetics, epigenetics, and biomarkers reviewed, Curr Psychiatry Rep, vol.2014, issue.10, pp.16-473

S. S. , P. V. , S. Babu-cl, S. Kumar-gp, and D. Bc, Bruxism: a literature review, J Indian Prosthodont Soc, vol.10, issue.3, pp.141-149, 2010.

S. Yj, L. M. Kato, T. , P. Hu, H. K. et al., Effects of botulinum toxin on jaw motor events during sleep in sleep bruxism patients: a polysomnographic evaluation, J Clin Med, issue.3, pp.10-291, 2014.

S. Jy, C. Nk, J. Sy, L. J. , K. Js et al., Risk of ischemic stroke with the use of risperidone, quetapine and olanzapine in elderly patients: a population-based, case-crossover study, J Psychopharmacol, issue.7, pp.27-638, 2013.

S. Aj, P. Aa, and A. J. , Botulinum injection for the management of myofascial pain in the masticatory muscles. A prospective outcome study, Br J Oral Maxillofac Surg, issue.3, pp.51-199, 2013.

S. Sree-s, Dysphagia : a review, J Pharm Sci Res, vol.2014, issue.69, pp.302-304

S. Lg and P. R. , Neuroleptic induced dysphagia, Dysphagia, vol.12, issue.4, pp.177-186, 1997.

S. P. , M. Mp, and S. Jc, La famille des récepteurs de la dopamine, Médecine/Sciences, vol.9, pp.12-20, 1993.

S. N. and W. A. Weiss-m, Schizophrenia and binge-eating disorders, J Clin Psychiatry, issue.7, pp.65-1016, 2004.

S. B. and A. Hd, Drug-induced dysphagia, Dysphagia, vol.8, issue.2, pp.154-159, 1993.

S. Dutt, C. , R. P. , T. D. , and P. M. , Botulinum toxin in the treatment of muscle specific oro-facial pain: a literature review, J Maxillofac Oral Surg, issue.2, pp.14-171, 2015.

S. F. and F. Hh, Drug-induced parkinsonism, Curr Treat Options Neurol, vol.11, issue.3, pp.162-171, 2009.

T. Sy and Y. Me, Philippe Pinel (1745-1826): liberator of the insane, Singapore Med J, issue.9, pp.45-410, 2004.

T. H. , U. H. Suzuki-t, S. Y. , S. H. , W. K. et al., Dental conditions in inpatients with schizophrenia: a large-scale multi-site survey, BMC Oral Health, vol.12, pp.32-42, 2012.

T. D. , K. C. , F. C. , D. G. Bo, and T. Le, Découvertes récentes sur la fonction et la plasticité des voies dopaminergiques du cerveau, Médecine/Sciences, issue.2, pp.26-165, 2010.

T. Pl and B. , Bioavailability and its assessment, J Vet Pharmacol Ther, issue.6, pp.27-455, 2004.

T. C. Troubles-de-la-deglutition, T. Em, D. T. , and T. Fi, Neur Psych Géria. [en ligne] Clinical management of negative symptoms of schizophrenia: an update, Pharmacol Ther, vol.2615, issue.153, pp.135-182, 2007.

U. G. , W. A. Wagner-a, K. C. , and R. M. , Recurrent mandibular dislocation under neuroleptic drug therapy, treated by bilateral eminectomy, J Cranio Maxillofacial Surgery, issue.3, pp.24-184, 1996.

V. Mn, B. A. , C. S. , and A. L. , Antipsychotics in bipolar disorders, Encephale, vol.30, issue.5, pp.417-441, 2004.

V. H. , S. K. , M. O. , L. S. , A. P. et al., Suicidal ideation and attempts in bipolar I and II disorders, J Clin Psychiatry, issue.11, pp.66-1456, 2005.

C. Villa-a and A. S. Cl, Diagnosis and management of xerostomia and hyposalivation, Therapeutics and Clinical Risk Management, vol.11, pp.45-51, 2015.
DOI : 10.2147/TCRM.S76282

V. D. and V. Jg, Biochimie. 2 e éd, 2004.

W. , H. Xf, and D. C. , Second generation antipsychotic-induced type 2 diabetes: a role for the muscarinic M3 receptor, CNS, issue.12, pp.27-1069, 2013.

W. , H. Xf, L. J. , and D. C. , Effects of olanzapine on muscarinic M3 receptor binding density in the brain relates to weight gain, plasma insulin and metabolic hormone levels, Eur Neupsychopharmacol, issue.5, pp.22-364, 2012.

Y. Dm, C. Yj, S. A. Xiong-wc, and M. L. , Synaptic dysfunction in schizophrenia, Adv Exp Med Biol, vol.970, pp.493-516, 2012.

Y. Ka, G. Kl, and W. Z. , The role of mesocorticolimbic dopamine in regulating interactions between drugs of abuse and social behaviour, Neuro Scie biobehav Rev, issue.3, pp.35-498, 2011.

Z. Rd, Diabetes mellitus and periodontal disease, Compendium, vol.12, issue.5, pp.324-332, 1991.

Z. Mr, N. M. , and H. M. , A mini review of serotonin and its receptors, International J medical reviews, vol.2014, issue.11, pp.39-45